We observed significantly lower FOLH1 expression in tumors exhibiting neuroendocrine differentiation compared to adenocarcinoma specimens, which was especially pronounced in pure high-grade neuroendocrine carcinoma. The gene discussed is FOLH1; the disease is neuroendocrine carcinoma.